Related Experiment Video
Updated: Aug 16, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Alterations in calcium handling in cardiac hypertrophy and heart failure
1Department of Physiology, University of Maryland School of Medicine, Baltimore 21201, USA. bbalke@heart.ab.umd.edu
Insights
Conflicting data on cardiac hypertrophy and heart failure effects on calcium handling exist due to varied models and disease stages. Longitudinal studies in well-matched animal models are crucial for understanding excitation-contraction coupling abnormalities.
Area of Science:
- Cardiology
- Molecular Biology
- Physiology
Background:
- Conflicting data exists regarding L-type Ca2+ channel density, intracellular Ca2+ transients, and Ca2+ sparks in cardiac hypertrophy and failure.
- Discrepancies stem from model-dependent effects, varied disease generation mechanisms, non-uniform disease distribution, and disease progression stage.
Purpose of the Study:
- To address discrepancies in understanding cardiac hypertrophy and failure effects on calcium handling.
- To highlight the need for standardized, longitudinal animal models for studying cardiac disease progression.
Main Methods:
- Review and analysis of existing data on cardiac hypertrophy and failure.
- Discussion of challenges in comparing results across different animal models and disease stages.
Main Results:
- Cardiac hypertrophy increases myocardial contractility, while heart failure decreases it, complicating direct comparisons.
- L-type Ca2+ channel behavior and SR function are dependent on the extent of disease expression.
Conclusions:
- Consistent data requires longitudinal studies using a single, well-characterized animal model that mimics human disease.
- Improved Ca2+ imaging and understanding of excitation-contraction coupling are vital for identifying abnormalities and defining treatments.
Abstract:
There is conflicting data concerning the effects of cardiac hypertrophy and failure on L-type Ca2+ channel density, the amplitude of the intracellular Ca2+ transients, and the characteristics of Ca2+ sparks. These discrepancies are probably due to multiple factors. First, the effects of cardiac hypertrophy on channel expression and cell adaptation are model dependent. Even within the same species, the mechanisms by which cardiac hypertrophy and heart failure are generated (genetic alteration, pressure overload, volume overload, high rate pacing, etc.) influence the results obtained. Second, with many animal models and diseased human hearts, the disease process is not uniformly distributed throughout the myocardium. Third, the effects on L-type Ca2+ channel behavior and SR function clearly depend on the extent of disease expression. Myocardial contractility increases with cardiac hypertrophy whereas it decreases with heart failure. Thus, it is difficult to compare results from different models of hypertrophy and heart failure at different stages of disease. More consistent data is likely to be obtained from longitudinal studies using a single animal model of disease. The challenge before us is to develop animal models that mimic human disease, which can be studied longitudinally during the progression of the disease process. This approach coupled with continued improvement in Ca2+ imaging and a greater understanding of normal E-C coupling, will enable us to identify precisely the abnormalities in E-C coupling that occur with the development of cardiac hypertrophy and heart failure and define the appropriate treatment modalities.
More Related Videos
Related Concept Videos
Pathophysiology of Heart Failure
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cellular Adaptation II: Hypertrophy

